AnaptysBio and Tesaro/GSK set post-trial briefing schedule in collaboration dispute

ANAPTYSBIO, INC

Trial held July 14-17, 2026 in Delaware Chancery Court over alleged breach of Collaboration Agreement.
Court granted joint stipulation: AnaptysBio opening brief due Aug 21, 2026.
Defendants' answering brief due Sep 25, 2026; AnaptysBio reply due Oct 9, 2026.
Post-trial argument scheduled for October 20, 2026.
No settlement or judgment announced; litigation remains ongoing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.